BiomaLearnFoodsNutrition factsNutrientsGuidesAnswersEvidence

Oat oil: the appetite emulsion that later trials did not confirm

Most human research with oat oil in it is about Olibra, also sold as Fabuless, an emulsion of palm and oat oil marketed to curb appetite. It is mostly palm oil, so none of its results are results for oat oil alone. The early randomized trial looked good. In 50 overweight women who had just dieted, weight regain over 18 weeks was 2.4 lb (1.1 kg) on the emulsion against 6.6 lb (3.0 kg) on placebo. Later trials did not repeat it. In 82 overweight adults over 12 weeks, 2.1 g twice a day gave 4.8 lb (2.17 kg) of weight loss against 3.7 lb (1.68 kg) on placebo, a gap that did not reach significance, and only 71 of the 82 were analyzed. In 18 lean men, and again in two trials of 24 volunteers each, the emulsion did not reduce how much people ate or how hungry they felt. The EU refused both claims made for it, that it helps you eat less and that it prolongs fullness.

Every statement here is tied to a source. The badge says what kind of evidence stands behind it: A is a meta-analysis or systematic review, E is the position of an expert body without its own analysis. How we verify →

The numbers, per 3.5 oz (100 g)

USDA entrykcalProteinFatCarbsFiber
Oil, oat8840 g100 g0 g0 g

These are the USDA entries that are oat oil, not foods made from it; they differ in cut, part, pack or preparation. Linked names have a page with the full profile and per-portion figures.

How much is actually in it

What your body absorbs

What cooking and storage change

What it does to your health

What people believe that the data does not support

Who this works differently for

The bottom line

As a cooking oil it is almost pure fat. USDA lists 100 g of fat per 3.5 oz (100 g), 19.6 g of it saturated, with 14.4 mg of vitamin E, 96 percent of the Daily Value in those 3.5 oz (100 g) of oil, from a single legacy record with no measured spread. In oils extracted in the lab from 16 Chinese oat cultivars, oleic acid averaged about 41 percent and linoleic acid about 39 percent of the fatty acids, and commercial oat oil may differ. A few small trials test parts of the story. Adding 15 g of oat polar lipids, a fraction of oat oil, to a bread breakfast lowered blood glucose and insulin over the next 2 hours compared with rapeseed oil in 20 healthy young adults. That was one meal, the abstract gives no size in mmol, and the research group has industry links. In 15 healthy men the palm and oat emulsion slowed transit from mouth to colon by about 45 minutes against milk fat, after a single dose. One crossover trial in 24 volunteers reported that the emulsion lowered dinner intake only when unprocessed, yet the processed version sat lower on the same table, 3.9 MJ against 4.2 MJ, so those numbers do not line up with the stated result. In 28 non-obese adults given 5 g of emulsion fat a day for two 3-week phases, average lunch intake did not change, and the 46 to 59 percent who ate less on a given day is a split close to half, which chance alone could produce. We found no evidence at all on oat oil and allergy, pregnancy, children, kidney disease or medicines, so this page has no safety section. Read that as missing data.

More from the same food group (fats and oils)

Sources

  1. oto-r2-01 · USDA FoodData Central SR Legacy, dataset
    Oil, oat (FDC 173576, SR Legacy, Fats and Oils): total fat 100 g per 100 g = 128% DV; saturated fat 19.62 g = 98% DV; vitamin E 14.4 mg = 96% DV; vitamin K 24.7 ug = 21% DV; Foundation samples 0, CoFID match none
    USDA FoodData Central, SR Legacy, FDC 173576 · checked 2026-09-29
  2. oto-r2-02 · food chemistry analysis
    The oat oils were particularly rich in monounsaturated oleic acid (C18:1) and polyunsaturated linoleic acid (C18:2), which constituted approximately 40.89 ± 0.02% and 38.53 ± 0.01% of the total oil content, respectively.
    Foods, 2025 · checked 2026-09-29
  3. oto-r2-04 · RCT
    A statistically significant delay in the appearance of sulfapyridine in serum was obtained after active treatment versus control treatment, corresponding to a 45-min longer orocecal transit time due to fat emulsion consumption.
    Scand J Gastroenterol, 2009 · checked 2026-09-29
  4. oto-r2-05 · RCT
    Compared with control, only unprocessed Fabuless reduced subsequent energy intake, although only during dinner (P < 0.01; control, processed and unprocessed: 4.3, 3.9 and 4.2 MJ, respectively) and not during lunch (3.6, 3.7 and 3.6 MJ).
    Eur J Clin Nutr, 2011 · checked 2026-09-29
  5. oto-r2-03 · RCT
    After breakfast, PLH substantially lowered postprandial glucose and insulin responses (iAUC 0-120 min) compared with RSO and WWB (p < 0.05).
    Nutrients, 2023 · checked 2026-09-29
  6. oto-r2-06 · RCT
    At 12 weeks, body weight was reduced in the test group (2.17 ± 0.46 kg standard error of the mean, p < .0001) and the control group (1.68 ± 0.42 kg, p < .0001).
    J Diabetes Sci Technol, 2012 · checked 2026-09-29
  7. oto-r2-09 · RCT
    During weight maintenance after significant body weight reduction, there was no significant increase in body weight in the test group (1.1+/-3.4 kg); the placebo group did gain weight (3.0+/-3.1 kg, P<0.001).
    Int J Obes (Lond), 2007 · checked 2026-09-29
  8. oto-r2-07 · RCT
    When consumed with a meal there was no evidence in lean men that this commercial lipid emulsion promotes satiation or suppresses short-term food intake.
    Physiol Behav, 2015 · checked 2026-09-29
  9. oto-r2-08 · RCT
    The structured lipid emulsion tested had no significant effect on the primary measures of food intake or appetite.
    Int J Obes (Lond), 2012 · checked 2026-09-29
  10. oto-r2-11 · EU claims register
    POL-HC-7119 Formulated palm and oat oil emulsion Helps to eat less. Helps to reduce weight regain after dieting. Non-authorised
    EU Register on nutrition and health claims, claim POL-HC-7119, snapshot 2026-09-21 · checked 2026-09-29
  11. oto-r2-12 · EU claims register
    POL-HC-7717 Palm/oat oil fatty acid In studies found to increase and prolong the sense of satiety. Helps to control appetite during the day. Increases the feeling of satiety Non-authorised
    EU Register on nutrition and health claims, claim POL-HC-7717, snapshot 2026-09-21 · checked 2026-09-29
  12. oto-r2-10 · RCT
    There was considerable individual variation in food intakes following consumption of the Olibra emulsion, with 46, 59 and 57% of subjects reducing their energy intakes at lunch on days 1, 8 and 22.
    Eur J Clin Nutr, 2006 · checked 2026-09-29

Review. Reviewed on 2026-09-29 for evidence level, dose and population context, and claims a reader could misread. Bioma Learn has no human medical reviewer at this time, and we say so rather than invent one. Methodology. This is information, not medical advice.